CEO Pascal Soriot says AstraZeneca is growing 'new branches' as Covid vaccine sales continue to fall

Nicole DeFeudis

Editor

AstraZeneca CEO Pascal Soriot has been “pruning the tree” for quite some time, cutting a slate of unwanted programs across a range of indications over …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

CEO Pascal Soriot says AstraZeneca is growing 'new branches' as Covid vaccine sales continue to fall

Nicole DeFeudis

Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Broad Institute paper offers potential new framework for treating Huntington’s disease

FDA rejects Atara's cell therapy for rare transplant complication, stock craters

Boehringer's schizophrenia asset fails Phase 3; GSK buys organoid biotech

A mixed year for deals and dollars left biotech execs hungry for a better 2025

Eli Lilly's Omvoh earns FDA approval for Crohn's disease

Vaccine patch startup collects an additional $16M to Series A

CEO Pas­cal So­ri­ot says As­traZeneca is grow­ing 'new branch­es' as Covid vac­cine sales con­tin­ue to fall

Editor

Sign up to read this article for free.

more like this

Bachem

Bubendorf, BL, Switzerland

CEO Pascal Soriot says AstraZeneca is growing 'new branches' as Covid vaccine sales continue to fall